-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II

Symposia: Chronic Lymphocytic Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jeff P. Sharman, MD1, Luca Laurenti, MD2*, Emmanuelle Ferrant3*, Luis Felipe Casado Montero4*, Stephen P Mulligan5*, Rosemary Harrup6*, Stephen Opat7*, Adalberto Ibatici8*, Roberto Marasca9, Paolo Sportoletti10*, Marcus Lefebure11*, Michelle Boyer12*, Yanwen Jiang12*, Simona Barlera13*, Oscar Cazares12* and Franck Morschhauser, MD, PhD14

1Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR
2Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Agostino Gemelli University Hospital Foundation IRCCS, Rome, Italy
3Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
4Hematology, Hospital General Universitario de Toledo, Toledo, Spain
5Royal North Shore Hospital, Sydney, AUS
6Royal Hobart Hospital and University of Tasmania, Tasmania, Australia
7Monash Health, Melbourne, VIC, Australia
8Division of Hematology and Bone Marrow Transplant, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
9University of Modena and Reggio Emilia, Modena, Italy
10Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato-Oncologica, University of Perugia, Perugia, Italy
11Roche Products Ltd, Welwyn Garden City, United Kingdom
12Genentech, Inc., South San Francisco, CA
13Parexel International, Milan, Italy
14Centre Hospitalier Régional Universitaire de Lille, Lille, France

Moritz Fürstenau, MD1*, Emelie Curovic Rotbain, MD, PhD2*, Laura Eurelings, MD, PhD3*, Sandra Robrecht, PhD4*, Julia Von Tresckow, MD5*, Adam Giza6*, Michael Gregor, MD7*, Patrick Thornton8*, Philipp Bernhard Staber, MD, PhD9, Tamar Tadmor, MD10*, Vesa Lindström11*, Gunnar Juliusson, MD, PhD12, Ann Janssens, MD13*, Christof Schneider, MD14*, Thomas Noesslinger, MD15, Martin Andres16*, Adrian Schmidt17*, Elisabeth Vandenberghe, MD18, Lev Shvidel, MD19*, Christian Bjørn Poulsen, MD, PhD20*, Henrik Frederiksen, MD, PhD21, Caspar Da Cunha-Bang, MD, PhD2*, Kourosh Lotfi22*, Rogier Mous, MD PhD23*, Martine E.D. Chamuleau, MD PhD24, Ka Lung Wu25, Margriet Oosterveld, MD26*, Jesus Duque-Afonso, MD27*, Christian Bogner28*, Thomas Wolff, MD29*, Johannes Schetelig, MD, MSc30, Ursula Vehling-Kaiser, MD31*, Christoph van Roye32*, Nadine Kutsch, MD6*, Anna Maria Fink, MD33*, Kirsten Fischer, MD33*, Emily Holmes34*, Matthias Ritgen35*, Eugen Tausch, MD14*, Stephan Stilgenbauer, MD14, Michael J. Hallek, MD36, Arnon P. Kater, MD, PhD37, Carsten Utoft Niemann, MD, PhD2*, Mark-David Levin38 and Barbara F. Eichhorst, MD39

1Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Koeln, Germany
2Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
3Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands
4German CLL Study Group, University of Cologne, Cologne, Germany
5Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
6Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany
7Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Lucerne, Switzerland
8Department of Haematology, Beaumont Hospital, RCSI, Cancer Trials Ireland, Dublin, Dublin, IRL
9Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
10Bnai Zion, Haifa, Israel
11Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
12Department of Hematology, Lund University Cancer Center, Lund, Sweden
13University Hospitals Leuven, Leuven, Belgium
14Department of Internal Medicine III, Division of CLL, University Hospital Ulm, Ulm, Germany
15Hanusch Hospital, Vienna, AUT
16Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
17Stadtspital Zürich Triemli, Zürich, Switzerland
18St. James's Hospital, Dublin, IRL
19Kaplan Medical Center, Rehovot, Israel, ISR
20Department of Hematology, Zealand University Hospital, Roskilde, Denmark
21Department of Hematology, Odense University Hospital, Odense, DNK
22University Hospital/Linkoping University, Linkoping, SWE
23Department of Hematology, University Medical Center Utrecht, Amsterdam, Netherlands
24Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
25ZNA Stuivenberg, Antwerp, Belgium
26Canisius-Wilhelmina Hospital, Nijmegen, NLD
27Univ. of Freiburg, Freiburg, DEU
28Klinikum Landshut, Landshut, DEU
29Onkologie-Lerchenfeld, Hamburg, DEU
30Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Saxony, Germany
31Outpatient Clinic, Landshut, Germany
32Onkologie Koblenz, Koblenz, Germany
33Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Cologne, Germany
34German CLL Study Group, University of Cologne, Cologne, Cologne, Germany
35Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
36University of Cologne, Cologne, DEU
37Amsterdam University Medical Center, Amsterdam, on behalf of HOVON, Netherlands
38Albert Schweitzer Hospital, Dordrecht, Netherlands
39University Hospital Cologne, Cologne, Germany

Tamar Tadmor, MD1,2*, Guy Melamed3*, Hilel Alapi4*, Sivan Gazit5*, Tal Patalon6* and Lior Rokach, Prof7*

1Technion, Ruth and Bruce Rappaport Faculty of Medicine,, Haifa,, Israel
2Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
3Kahn Sagol Maccabi Research & Innovation Center, Maccabi Healthcare Services, T, Tel-Aviv, Israel
4Kahn Sagol Maccabi Research & Innovation Center, Maccabi Healthcare Services,, Tel Aviv, Israel
5Kahn Sagol Maccabi Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
6Kahn Sagol Maccabi Research & Innovation Center, Maccabi Healthcare Services, Tel-Aviv, Israel, Tel Aviv, Israel
7Ben-Gurion University of the Negev,, Department of Software and Information Systems Engineering,, Beer-sheva, Israel

Linlin Cao1*, Song Hao2*, Cuicui Wang2*, Qiang Xu2*, Chenyang Zhou2*, Maogui Hu2*, Jing Ming2*, Guolin Wu2*, Dandan Fan2*, Yuanyuan Feng2*, Xinchen Wang2*, Hailiang Chu3* and Kaiyang Ding2*

1Department of Hematological Oncology, Anhui Province Cancer Hospital, Anhui, China
2Department of Hematological Oncology, Anhui Province Cancer Hospital, Hefei, China
3Department of hematology ,Bozhou People's Hospital, Bozhou, China

Merieme Bensalah, PharmD1*, Amal Messaoudi1*, Carole Fleury1*, Giulia Tueur1*, Rémi Letestu, MD, PhD1,2*, Marine Armand, PhD3*, Sabine Brechignac, MD4,5*, Sarah Ivanoff, MD4,6*, Valérie Vidal, MD4,6*, Ramy Rahmé, MD, MSc4,6*, Chadi Al Nawakil, MD7*, Thorsten Braun, MD, PhD4,6, Catherine Thieblemont, MD8, Cymbalista Florence, MD, PhD1,2*, Vincent Levy, MD, PhD7*, Fanny Baran-Marszak, MD, PhD2,9* and Grégory Lazarian, PharmD, PhD1,2*

1Hematology Laboratory, Avicenne University Hospital, Assistance Publique – Hôpitaux de Paris, Bobigny, France
2INSERM U978, Université Sorbonne Paris Nord, Bobigny, France
3Department of Biological Hematology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, PARIS, France
4UFR SMBH, Sorbonne Paris Nord University, Bobigny, France
5Clinical Hematology, Avicenne Hospital, Greater Paris University Hospitals (AP-HP), Bobigny, France
6Clinical Hematology, Avicenne University Hospital, Assistance Publique – Hôpitaux de Paris, Bobigny, France
7Département de Recherche Clinique, Hôpitaux Universitaire Paris Seine Saint Denis (HUPSSD), Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France
8Hospital Saint-Louis, Paris, France
9INSERM U978, University of Paris 13, Bobigny, France

Krzysztof Jamroziak, MD, PhD1*, Elzbieta Iskierka-Jazdzewska, MD, PhD2*, Sebastian Giebel, MD, PhD3*, Kamil Wisniewski, MD, PhD4*, Joanna Drozd-Sokolowska, MD, PhD1*, Tadeusz Robak5,6*, Justyna Rybka, MD, PhD7*, Weronika Piszczek, MD8*, Monika Joks, MD, PhD9*, Anna Paulina Dabrowska-Iwanicka, MD, PhD10, Andrzej Mital, MD, PhD11*, Paweł Steckiewicz, MD12*, Ewa Lech-Maranda, MD, PhD13*, Marcin Jasinski, MD1*, Marcin Rymko, MD, PhD14*, Dawid Marciniak, MD15*, Tomasz Wrobel, MD, PhD16*, Lidia Gil, MD, PhD9, Joanna Romejko-Jarosinska, MD, PhD17*, Dorota Kruk-Kwapisz, MSc18*, Agnieszka Chudy, PhD19*, Krzysztof Giannopoulos, MD, PhD20*, Tomasz Stoklosa, MD, PhD21 and Bartosz Michal Pula, MD, PhD22*

1Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
2Copernicus Memorial Hospital, Medical University of Łódź, Lodz, Poland
3Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
4Department of Hematology, Instutute of Hematology and Trasnfusion Medicine, Warsaw, POL
5Department of Hematology, Medical University of Lodz, Lodz, Poland
6Copernicus Memorial Hospital, Lodz, Poland
7Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
8Hematology Department, Rydygier Provincial Polyclinical Hospital in Toruń, Torun, Poland
9Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
10Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
11Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland
12Department of Hematology, Holy Cross Cancer Center, Kielce, Poland
13Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
14Hematology Department, Rydygier Provincial Polyclinical Hospital in Torun, Torun, POL
15Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
16Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
17Department of Lymphoid Malignancies, Marie Sklowdoska-Curie National Research Institute of Oncology, Warszawa, Poland
18Medical University of Warsaw, Warsaw, Poland
19Department of Tumor Biology and Genetics, University Clinical Center, Medical University of Warsaw, Warsaw, Poland
20Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
21Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland
22Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Masovian Voivodeship, Poland

Emelie Curovic Rotbain, MD, PhD1,2*, Mikkel Werling, MSc1*, Casper Møller Frederiksen, PhD1*, Christian Bjørn Poulsen, MD, PhD3*, Martin Hutchings, MD, PhD1,4, Caspar Da Cunha-Bang, MD, PhD1* and Carsten Utoft Niemann, MD, PhD1,4*

1Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2Hematology Group, Danish Cancer Institute, Copenhagen, Denmark
3Department of Hematology, Zealand University Hospital, Roskilde, Denmark
4Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Huayuan Zhu1*, Yi Miao, MD2*, Shuchao Qin, MD PHD2*, Ming Liu2*, Yi Xia2*, Luomengjia Dai2*, Tonglu Qiu, MD2*, Chong-Yang Ding3*, Hairong Qiu2*, Chun Qiao2*, Yujie Wu2*, Fei Li4, Xiao Lu, MD2*, Wei Xu2*, Lei Fan2* and Jianyong Li, MD5

1Pukou CLL Center, Pukou Division of Jiangsu Province Hospital, Nanjing, Jiangsu, China
2Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
3Department of Nuclear Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
4Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
5First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Cecelia Miller, PhD1, Ying Huang, MS, MA2, John N. Allan, MD3, Seema A. Bhat, MD4*, David A. Bond, MD, BS5, Danielle M. Brander, MD6, John C. Byrd, MD7, Julio C. Chavez, MD8, Elise A. Chong, MD9, Alexey Danilov, MD, PhD10, Mark R Dowling, MBBS, PhD11, Kaitlyn M. Dvorak-Kornaus, PhD5*, Paul J. Hampel, MD12, Carrie I Ho, MD13, Prioty Islam, MD14*, Nikita Malakhov, MD15, Matthew Matasar, MD, MS16, Sarah Miller, BS17*, Sameer A. Parikh, MBBS12, Kari G. Rabe, MS18*, Joanna M. Rhodes, MD, MSCE19*, Lindsey Roeker, MD20, Kerry A. Rogers, MD5, Aditi Saha, MBBS8, Alan P Skarbnik, MD21, Hamish W Scott, MD22*, Jake Schade, BA23*, Mazyar Shadman, MD, MPH24*, Geoffrey Shouse, PhD, DO25, Deborah M. Stephens, DO26, Meghan C. Thompson, MD14, Philip A. Thompson, MBBS, FRACP, FRCPA27, Yucai Wang, MD, PhD12, Jennifer A. Woyach, MD28, Max Yano, MD, PhD29*, Zulfa Omer, MD30 and Adam S Kittai, MD31

1Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
3Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
4Division of Hematolopgy, The Ohio State University, Columbus, OH
5Division of Hematology, The Ohio State University, Columbus, OH
6Duke University, Durham, NC
7Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
8Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
9Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
10City of Hope National Medical Center, Duarte, CA
11Peter MacCallum Cancer Centre, Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, VIC, Australia
12Division of Hematology, Mayo Clinic, Rochester, MN
13Division of Hematology and Oncology, University of Washington, Seattle, WA
14Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
15Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
16Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ
17Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
18Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
19Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
20Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
21Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, NC
22Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
23Rutgers Cancer Institute, New Brunswick, NJ
24Fred Hutch Cancer Center, University of Washington, Seattle, WA
25City of Hope Cancer Center, Duarte, CA
26University of North Carolina Chapel Hill, Chapel Hill, NC
27Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
28Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
29College of Medicine, The Ohio State University, Columbus, OH
30Division of Hematology, University of Cincinnati, Cincinnati, OH
31Icahn School of Medicine at Mount Sinai, New York, NY

Anjali Lankford, MD1*, Mahesh Swaminathan, MD2, Amrit S. Gonugunta, MD3*, Himachandana Atluri, MD2, Hannah Goulart, MD4, Koji Sasaki, MD2, Guilin Tang, MD, PhD5*, Rashmi Kanagal-Shamanna, MD6, Jan A. Burger, MD, PhD 4, Alessandra Ferrajoli, MD2, Hagop Kantarjian, MD2, William G. Wierda7 and Nitin Jain, MD8

1Department of Internal Medicine, The University of Texas Health Science Center McGovern Medical School, Houston
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX
4MD Anderson Cancer Center, Houston, TX
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX

Allison M. Winter, MD1, Olivia Landever1*, Hiruni Mendries1*, Willem Van Heeckeren, MD, PhD2*, Chieh-Lin Fu, MD3, Robert M. Dean, MD1, Taylor R. Brooks, MD1, Deepa Jagadeesh, MD1, Paolo F. Caimi1 and Brian T. Hill, MD, PhD1

1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL

Yuqin Song, MD1, Keshu Zhou, MD2*, Hongmei Jing, MD3, Geoffrey Chong4, Jianqiu Wu, PhD5*, Wei Liu, MD6*, Zengjun Li7*, Ming Jiang, PhD8*, Mei Lan, MD9*, Kaiyang Ding10*, Guohui CUI11*, Tingyu Wang12*, Xutao Guo, MD13*, Sujun Gao14*, Constantine S. Tam, MBBS, MD15, Haiyan Yang, PhD16, Fang Zhu17*, Wei Yang18*, Jian-Qing Mi19, Liping Su20, Ke Fang21*, Ziyi Liu21*, Lindsey Roeker, MD22, Chan Y. Cheah, MBBS DMSc23, Jianyong Li, MD24 and Lu-Gui Qiu, MD6

1Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
2Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
3Peking University Third Hospital, Beijing, China
4Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
5Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, AL, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
7Cancer Hospital of Shandong First Medical University, Jinan, China
8West China Hospital,Sichuan University, Chengdu, China
9The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, CHN
10Department of Hematological, Anhui Province Cancer Hospital, Hefei, China
11Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, WUHAN, CHN
12State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sci, Tian Jin, China
13Department of Hematology, Nanfang Hospital of Southern Medical University, GuangZhou, China
14Department of Hematology, The First Hospital of Jilin University, Changchun, China
15Monash University, Melbourne, VIC, Australia
16Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
17Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Sc, Wuhan, CHN
18Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
19Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
20Shanxi Province Cancer Hospital, Taiyuan, China
21Dizal Pharmaceutical, Shanghai, China
22Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
23Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
24First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Mazyar Shadman, MD, MPH1,2, Talha Munir, MBBS, PhD3, Tadeusz Robak4*, Jennifer R. Brown, MD, PhD5, Brad S. Kahl, MD6, Paolo Ghia, MD, PhD7,8, Tian Tian, PhD9*, Andy Szeto9*, Roman Korolkiewicz10*, Constantine S. Tam11* and Wojciech Jurczak, MD, PhD12

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
4Department of Hematology, Medical University of Lodz, Lodz, Poland
5Dana-Farber Cancer Institute, Boston, MA
6Washington University School of Medicine, Saint Louis, MO
7IRCCS Ospedale San Raffaele, Milan, Italy
8Università Vita-Salute San Raffaele, Milano, Italy
9BeiGene USA, Inc, San Mateo, CA
10BeiGene USA, Inc, San Mateo
11Alfred Health and Monash University, Melbourne, VIC, Australia
12Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland

Lukas Peter Frenzel1*, Laura Beckmann, MD1*, Sandra Robrecht, PhD2*, Can Zhang, PhD3*, Anna Maria Fink, MD3*, Othman Al-Sawaf, MD3, Christof Schneider, MD4*, Brenda Chyla5, Hyun Yong Jin, PhD6*, Yanwen Jiang6*, Tim H. H. Brummendorf, MD7, Michael Hallek, MD8*, Barbara F. Eichhorst, MD8, Kirsten Fischer, MD9*, Fabian Beier, MD10,11* and Susanne Isfort12*

1Faculty of Medicine and Cologne University Hospital, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany, Cologne, Germany
2German CLL Study Group, University of Cologne, Cologne, Germany
3Faculty of Medicine and Cologne University Hospital, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany, Cologne, Germany, Cologne, Germany
4Department of Internal Medicine III, Division of CLL, University Hospital Ulm, Ulm, Germany
5AbbVie Inc, North Chicago, IL
6Genentech, Inc., South San Francisco, CA
7Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Aachen, Aachen, Germany
8Department I of Internal Medicine, Faculty of Medicine and Cologne University Hospital, Cologne, Germany
9Faculty, Cologne, Germany
10Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Medical Faculty, Aachen, Germany
11Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany
12Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany

Lugui Qiu1, Zhuogang Liu2*, Shuhua Yi, MD3*, Thanh Nguyen, MD4*, Wen-Juan Yu5*, Keshu Zhou, MD6*, Haiwen Huang, MD7*, Udomsak Bunworasate, MD8*, Man Huynh, MD9*, Hui Zhou, MD10, Su-Peng Yeh, MD11*, Yiqiu Wang, MD12*, Xiaofeng Liu, MS12* and Wei Fu, MM12*

1State Key Laboratory of Experimental Hematology, National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
2Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
4National Institute of Hematology and Blood Transfusion, Hanoi, Viet Nam
5Department of Hematology, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
7Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
8Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
9Blood Transfusion Hematology Hospital, Hochiminh City, Viet Nam
10Department of Lymphoma & Hematology, Hunan Cancer Hospital and Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
11Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
12AstraZeneca, Shanghai, China

Rodrigo Fonseca, MD1*, Diana Zamora, MD2*, Fan Leng3*, Christie C Ngo4*, Jose F. Leis, MD, PhD5, Mazie Tsang, MD6 and Talal Hilal, MD7

1Internal Medicine, Mayo Clinic Arizona, Scottsdale, AZ
2Creighton University, Phoenix, AZ
3Division of Information Technology, Mayo Clinic, Rochester, MN
4Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN
5Mayo Clinic, Phoenix, AZ
6Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
7Division of Hematology and Oncology, Mayo Clinic Arizona, Phoenix, AZ

Jing-Zhou Hou, MD, PhD1, Rushir Choksi, MD1*, Anupama Vasudevan, BDS, MPH, PhD2*, Anna Rui, MPH2*, Poras Davé, MHA2*, Mike Gart, MBA2*, Brandon Wang, MBA2*, Prateesh Varughese, PharmD, MBA2* and Simon Blanc, MD2

1University of Pittsburgh Medical Center, Pittsburgh, PA
2IntegraConnect PrecisionQ, West Palm Beach, FL

Paolo Ghia, MD, PhD1, Loic Ysebaert, MD, PhD2*, Ann Janssens, MD, PhD3*, Mohamed Fouad4*, Claudio Schioppa5*, Jose-Angel Hernandez Rivas, MD, PhD6* and Alessandra Tedeschi, MD7*

1Università Vita-Salute San Raffaele, Milano, Italy
2Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
3UZ Leuven Gasthuisberg, Leuven, Belgium
4Johnson & Johnson Middle East FZ-LLC, Dubai, United Arab Emirates
5Janssen Pharmaceutica NV, Beerse, Belgium
6Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
7Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Constantine S. Tam, MD, MBBS1, Stephen S. Opat, MBBS, FRACP, FRCPA2, Eileen Grace Merriman, MD, FRACP, FRCPA3*, Jan A. Burger, MD, PhD 4, Emma Verner, MBBS5*, Paula Marlton6*, David Gottlieb, MD, MBBS, FRACP, FRCPA7*, Ian W. Flinn, MD, PhD8, Sumit Madan, MD9, Matthew Ku, MBBS, PhD10*, Radha Prathikanti, MPH, MBA11*, Heather Allewelt, MD11*, Tian Tian, PhD11*, Remus Vezan, MD, PhD11* and Gavin Cull, MBBS, DM, FRACP, FRCPA12

1Alfred Hospital and Monash University, Melbourne, VIC, Australia
2Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
3NorthShore Hospital, Auckland, New Zealand
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
6Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia
7Westmead Institute for Medical Research, Sydney, NSW, Australia
8Tennessee Oncology/OneOncology, Nashville, TN
9Banner MD Anderson Cancer Center at Banner Gateway Medical Center, Gilbert, AZ
10St Vincent’s Hospital, Melbourne, VIC, Australia
11BeiGene USA, Inc, San Mateo, CA
12Sir Charles Gairdner Hospital, Perth, Australia

Luc-Matthieu Fornecker, MD, PhD1*, Rémi Letestu, MD, PhD2*, Nanthara Shritaran, MS3*, Emmanuelle Ferrant4*, Fressia Honeyman, MD5*, Therese Aurran-Schleinitz, MD6*, Fatiha Merabet, MD7*, Pierre Morel, MD, PhD8*, Abderrazak El Yamani, MD9*, Jehan Dupuis, MD10*, Kamel Laribi, MD11*, Stephane Lepretre, MD12*, Lysiane Molina, MD13*, Hugo Legendre, MD14*, Chadi Al Nawakil, MD15*, Bruno Villemagne, MD16*, Anne-Sophie Michallet, MD, PhD17*, Béatrice Mahé, MD18*, Omar Benbrahim, MD19*, Laurence Sanhes, MD20*, Caroline Dartigeas, MD21*, Aline Clavert, MD22* and Vincent Levy, MD, PhD15*

1Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
2avicenne hospital, Avicenne, France
3Unité de Recherche Clinique, Hopital Avicenne, Bobigny, France
4Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’Hématologie Clinique, Pierre-Bénite, France
5Institut de cancérologie de la loire, ST PRIEST EN JAREZ CEDEX, FRA
6Institut Paoli Calmettes, Marseille, France
7andre mignot hospital, LE CHESNAY, FRA
8Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
9Centre Hospitalier de Blois, Blois, FRA
10APHP, Creteil, Creteil, FRA
11Hematology Department, Le Mans Hospital, Le Mans, France
12Centre Henri Becquerel, Rouen, FRA
13CHU grenoble, grenoble, France
14CHU de la réunion, Saint Pierre, FRA
15Département de Recherche Clinique, Hôpitaux Universitaire Paris Seine Saint Denis (HUPSSD), Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France
16CH la roche sur yon, La Roche Sur Yon, FRA
17Centre Leon Berard, LYON, France
18CHU nantes, Nantes, FRA
19HOPITAL LA SOURCE, La Source, FRA
20Centre Hospitalier Perpignan, Perpignan, France
21Service Hematologie, Tours, FRA
22CHU Angers, Angers, FRA

Christina-Nefeli Kontandreopoulou1*, Christos Stafylidis, MD, MSc1*, Vassiliki Labropoulou2*, Stavroula Smilakou3*, Dimitra Vlachopoulou1*, Iraklis Patsialos, MD1*, Stavroula Syriopoulou1*, Alexandros Gkikas, MD2*, Eleftherios N. Athanasopoulos4*, Anastasios Vogiatzakis3*, Eleni Panousi3*, Georgios Kyriakakis1*, Amalia Anastasopoulou1*, Marina Mantzourani, MD, PhD1* and Panagiotis T Diamantopoulos, MD, PhD1

1Hematology Unit, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
2School of Health Sciences, Faculty of Medicine, Hematology Division, University of Patras, Patras, Greece
3Department of Microbiology, Laikon General Hospital, Athens, Greece
4Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

Piers E.M. Patten, MBChB, FRCP, FRCPath, PhD1,2*, Arnon P. Kater, MD, PhD3, Jennifer A. Woyach, MD4, Jianyong Li, MD5, Talha Munir, MBBS, PhD6, Tommi Salmi, MD7*, Patrick Phuong8*, Tian Tian, PhD8* and Mazyar Shadman, MD, MPH9,10

1Comprehensive Cancer Centre, King's College London, London, United Kingdom
2King's College Hospital, London, United Kingdom
3Lymphoma and Myeloma Research Amsterdam, Amsterdam, Netherlands
4The Ohio State University Comprehensive Cancer Center, Columbus, OH
5First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
6Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
7BeiGene International GmbH, Basel, Switzerland
8BeiGene USA, Inc, San Mateo, CA
9Fred Hutchinson Cancer Research Center, Seattle, WA
10Division of Hematology and Oncology, University of Washington, Seattle, WA

Matthew S. Davids, MD, MMSc1, John M. Burke2, Jennifer A. Woyach, MD3, Mina Shahkarami4*, Katherine Eakle4*, Jinnie Ko4*, Vivek S. Chopra4*, Weize Huang4*, Rona Farighi4*, Richard H. Ko4*, Jeff P. Sharman, MD5 and William G. Wierda6

1Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
2Rocky Mountain Cancer Centers, Aurora, CO
3Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
4Genentech, Inc., South San Francisco, CA
5Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR
6The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH